Clinical Trials Directory

Trials / Completed

CompletedNCT03811873

Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates

Assessment of Vertebral Fracture Risk Using VFA and Vertebral Strength Assessment With DXA-Finite Element Analysis in Liver Transplant Recipients in Pretransplant Period

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The researchers are trying to compare the effectiveness of Vertebral Fracture Assessment (VFA) in addition to the current standard of care spine x-ray in evaluation pre-liver transplant patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDual x-ray absorptiometryDEXA is a means of measuring bone mineral density (BMD) using spectral imaging. Two X-ray beams, with different energy levels, are aimed at the bones. Soft tissue absorption is subtracted out, then the bone mineral density (BMD) can be determined from the absorption of each beam by bone.
OTHERVertebral Fracture AssessmentLumbar/thoracic spine x-ray and labs assessed for bone turnover markers.

Timeline

Start date
2019-02-18
Primary completion
2022-07-27
Completion
2022-08-30
First posted
2019-01-22
Last updated
2023-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03811873. Inclusion in this directory is not an endorsement.

Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates (NCT03811873) · Clinical Trials Directory